Effects of age, immune landscape, and response to trastuzumab (H) in HER-2 positive (HER2+) breast cancer in NCCTG (Alliance)-N9831.

Soyano, AE; Serie, D; Mashadi-Hossein, A; Warren, S; -Otero, GC; Knutson, KL; Perez, EA; Moreno-Aspitia, A; Thompson, EA; Chumsri, S

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):